Sunita Nathan to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications Sunita Nathan has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.336
-
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era. Biol Blood Marrow Transplant. 2020 06; 26(6):1137-1143.
Score: 0.176
-
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia. Blood Adv. 2018 11 13; 2(21):2922-2936.
Score: 0.161